Paola Nasuti

Real-World Evidence Senior Strategy Lead UCB

Paola Nasuti is Senior Strategy Lead in Real-World Evidence (RWE) at UCB, where she shapes global strategies to generate impactful evidence for regulators, clinicians, patients, and payers. With over 15 years of experience, she specialises in designing innovative RWE studies and translating complex data into actionable insights that guide drug development and market access. Paola has led observational studies across diverse therapy areas and geographies, driving solutions that influence clinical and commercial decision-making worldwide.

Seminars

Wednesday 1st April 2026
Round Table: Leveraging Real-World Evidence to Shape Early Biomarker & Precision Medicine Strategies in Europe
2:20 pm
  • How RWE helps us understand “who the patients really are”: Practical ways teams use real-world data to identify the right patient groups early on, even before trials begin
  • Using early insights to shape better clinical trials: How early signals from real-world and genomic data can guide inclusion criteria, endpoints, and trial design decisions
Paola Nasuti Speaker at 16th World Clinical Biomarkers & Companion Diagnostics Summit Europe